Is the price fair?
What NHC's price assumes
National HealthCare Corporation trades at 25.3× earnings against 19.7× for the median Medical Care Facilities name, more expensive than its own group.
25.3
Trailing P/E · Medical Care Facilities median 19.7 · 1.29× the median: the market pays up for this one
- Price / sales
- 1.65
Price / sales · as of 2026-Q1
- Free cash flow yield
- 4.7%
Free cash flow yield · Medical Care Facilities median 7.8%
- Growth the price implies
- +6.6%
Growth the price implies · The price pays for +6.6% free cash flow growth a year for a decade; the business has delivered +58% a year over the last three.
Details›
- Price / book2026-Q1
- 2.31
- EV / EBIT2026-Q1
- 18.7
- EV / sales2026-Q1
- 1.59
- Healthcare median P/E362 names
- 31.5
- Medical Care Facilities median P/E29 names
- 19.7
- Free cash flow, trailing twelve months
- $147M
- Market capitalisation
- $3.15B
- 3-year revenue growth
- +13%
- 3-year free cash flow growth
- +58%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $137.78 |
| Its own P/E history, median | $147.11 |
| Its own P/E history, upper quartile | $191.52 |
| 52-week range | $99.00 – $235.83 |
| Today | $224.55 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.